Shree Ganesh Remedies Ltd Financials
Company Logo

Shree Ganesh Remedies Ltd Financial Statement

Shree Ganesh Remedies Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
Revenue25.33
Operating Expense17.37
Net Profit3.45
Net Profit Margin13.62
Earning Per Share2.69
EBIDTA7.83
Effective Tax Rate12.81

Shree Ganesh Remedies Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual108.60
Operating Expenses Annual69.38
Operating Profit Annual42.94
Interest Annual2.08
Depreciation9.05
Net Profit Annual23.10
Tax Annual8.20

Shree Ganesh Remedies Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning8.66
Cash Flow from Operations30.45
Cash Flow from Investing-33.18
Cash Flow from Financing9.85
Cash Flow at the End15.78

Shree Ganesh Remedies Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)35.65
PBIT Margin (%)30.79
PBT Margin (%)-20.54
Net PROFIT Margin (%)22.34
Return On Networth / Equity (%)26.87
Return On Networth /Employed (%)27.76
Return On Assets (%)20.10
Total Debt / Equity (X)0.33
Asset Turnover Ratio (%)0.90

Shree Ganesh Remedies Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual95.44
Total Current Assets Annual77.53
Non Current Assets Annual114.45
Total Shareholders Funds Annual145.19
Total Assets Annual191.98

Shree Ganesh Remedies Ltd Earning Calls

EPS (INR)

Expected

2.69

Reported

2.68

Surprise

-0.37%

Mar 2025

EPS beaten by -0.37%

Dec 2024

EPS beaten by 0.00%

Sep 2024

EPS beaten by 0.00%

FAQS on Shree Ganesh Remedies Ltd Financials

As of Aug 19, 2025, Shree Ganesh Remedies Ltd has a market capitalization of 913.01 Cr. Value Research classifies it as a Small-Cap company.

Yes, Shree Ganesh Remedies Ltd is with a debt-to-equity ratio of 0.26.

In FY 2024 , Shree Ganesh Remedies Ltd recorded a total revenue of approximately 108.60 Cr marking a significant milestone in the company's financial performance.

Shree Ganesh Remedies Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.5% and 0.1% annually, respectively..

Shree Ganesh Remedies Ltd's current PE ratio is 39.52.

Shree Ganesh Remedies Ltd's ROCE averaged 19.9% from the FY ending March 2023 to 2025, with a median of 18.2%. It peaked at 24.5% in March 2024, reflecting strong capital efficiency over the period..

Shree Ganesh Remedies Ltd's latest EBIT is Rs. 33.38 Cr, surpassing the average EBIT of Rs. 30.86 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions